Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for upregulating immune responses using combinations of anti-RGMb and anti-PD-1 agents

Methods for upregulating immune responses using combinations of anti-RGMb and anti-PD-1 agents

US Patent 12139535 · Granted Nov 12, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method of assessing the efficacy of a test agent for modulating programmed death2025
Mesothelin chimeric antigen receptor (CAR) and antibody against PD-L1 inhibitor 2025
KIR3DL3 as an HHLA2 receptor, anti-HHLA2 antibodies, and uses thereof2024
Antibody molecules to PD-1 and uses thereof2023
Compositions and methods for identification, assessment, prevention, and treatme2023
Anti-phosphotyrosinylated programmed death 1 (PD-1) monoclonal antibodies, metho2022
Agents that modulate RGMb-neogenin-BMP signaling and methods of use thereof2022
Agents that modulate RGMb-neogenin-BMP signaling and methods of use thereof2022
Mesothelin chimeric antigen receptor (CAR) and antibody against PD-L1 inhibitor 2022
Methods and compositions for the treatment of persistent infections and cancer b2022
Agents that modulate immune cell activation and methods of use thereof2022
Agents that modulate immune cell activation and methods of use thereof2022